Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity

Journal of Oral Pathology and Medicine

Volumn 28, Issue 3, 1999, Pages 97-101

  Devoll, Robert E ^a   Li, Wei ^a   Woods, Kendra V ^b   Pinero, Gerald J ^a   Butler, William T ^a   Farach Carson, Mary C ^a   Happonen, Risto Pekka ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Carcinoma; Immunolocalization; Mucosa; Oral cancer; Osteopontin

Indexed keywords

CANCER CELL; CARCINOMA IN SITU; CELL LINE; IMMUNOANALYSIS; OSTEOPONTIN;

EID: 0033105549     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.1999.tb02004.x     Document Type: Article

References (28)

1. SENGER DR, PERRUZZI CA, PAPADOPOULOS A, TENEN DG. Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim Biophys Acta 1989; 996: 43-8.
2. CRAIG AM, BOWDEN GT, CHAMBERS AF, SPEARMAN MA, GREENBERG AH. Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts. Int J Cancer 1990; 46: 133-7.
3. BALLAHCENE A, CASTRONOVO V. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 1995; 146: 95-100.
4. BROWN LF, PAPADOPOULOS-SERGIOU A, BERSE B, et al. Osteopontin expression and distribution in human carcinomas. Am J Pathol 1994; 145: 610-23.
5. DENHARDT DT, BUTLER WT, CHAMBERS AF, SENGER DR. Osteopontin: role in cell signalling and adhesion. New York: New York Acad Sci 1995: Vol 760.
6. DAVIES J, WARWICK J, TOTTY N, PHILIP R, HELFRICH M, HORTON M. The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 1989; 109: 1817-26.
7. SOMERMAN MJ, PRINCE CW, BUTLER WT, FOSTER RA, MOEHRING JM, SAUK JJ. Cell attachment activity of the 44 kilodalton bone phosphoprotein is not restricted to bone cells. Matrix 1989; 9: 49-54.
8. YUE TL, MCKENNA PJ, OHLSTEIN EH, et al. Osteopontin-stimulated vascular smooth muscle cell migration is mediated by β3 integrin. Exp Cell Res 1994; 214: 459-64.
9. HRUSKA KA, ROLNICK F, HUSKEY M, ALVEREZ U, CHERESH D. Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity. Endocrinology 1995; 136: 2984-92.
10. MIYAUCHI A, ALVAREZ J, GREENFIELD EM, et al. Recognition of osteopontin and related peptides by an αvβ3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 1991; 266: 20369-74.
11. LOPEZ CA, DAVIS RL, MOU K, DENHARDT DT. Activation of signal transduction pathways by osteopontin. Ann N Y Acad Sci 1995; 760: 324-6.
12. WEBER GF, ASHKAR S, GLIMCHER MJ, CANTOR H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996; 271: 509-12.
13. NEMIR M, DEVOUGE MW, MUKHERJEE BB. Normal rat kidney cells secrete both phosphorylated and nonphosphorylated forms of osteopontin showing different physiological properties. J Biol Chem 1989; 264: 18202-8.
14. RITTER NM, FARACH-CARSON MC, BUTLER WT. Evidence for the formation of a complex between osteopontin and osteocalcin. J Bone Miner Res 1992a; 7: 877-85.
15. RITTER NM, FARACH-CARSON MC, BUTLER WT. Osteopontin (OPN) binding to ECM proteins. Connect Tissue Res 1992b; 27: 121.
16. GUO X, ZHANG YP, MITCHELL DA, DENHARDT DT, CHAMBERS AF. Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell. Mol Cell Biol 1995; 15: 476-87.
17. CHAMBERS AF, BEHREND EI, WILSON SM, DENHARDT DT. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Res 1992; 12: 43-8.
18. SATOH M, HATAKEYAMA S, SASHIMA M, SUZUKI A. Immunohistochemical detection of ras 21 in oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol 1992; 74: 469-72.
19. SARANATH D, BHOITE LT, MEHTA AR, SANGHAVI V, DEO MG. Loss of allelic heterozygosity at the Harvey ras locus in human oral carcinoma. J Cancer Res Clin Oncol 1991; 117: 484-8.
20. FIELD JK. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol, 1992; 28: 67-76.
21. SARANATH D, CHANG SE, BHOITE LT, et al. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 1991; 63: 573-8.
22. FIELD JK, YIAGNISIS M, SPANDIDOS DA, et al. Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma. Eur J Surg Oncol 1992; 18: 168-76.
23. DEVOLL RE, PINERO GJ, APPELBAUM E, et al. Improved immunohistochemical staining of osteopontin (OPN) in paraffin embedded archival bone specimens following antigen retrieval: anti-human OPN antibody recognizes multiple molecular forms. Calcif Tissue Int 1997; 60: 380-6.
24. KRAMER IR, LUCAS RB, PINDBORG JJ, SOBIN LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978; 46: 518-39.
25. WAHI P, COHEN B, LUTHRA UK, TORLONI H. Histological typing of oral and oropharyngeal tumors. International histological classification of tumors. No. 4. Geneva: World Health Organization, 1971.
26. PINERO GJ, FARACH-CARSON MC, DEVOLL RE, AUBIN JE, BRUNN JC, BUTLER WT. Bone matrix proteins in osteogenesis and remodeling in the neonatal rat mandible as studied by immuno-localization of osteopontin, bone sialo-protein, α2HS-glycoprotein and alkaline phosphatase. Arch Oral Biol 1995; 40: 145-55.
27. YOUNG MF, KERR JM, TERMINE JD, et al. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN). Genomics 1990; 7: 491-502.
28. NOWELL PC. The clonal evolution of tumor cell populations. Science 1976; 194: 23.